Selected research
Market Analysis & Forecast
Global Blonanserin Tablets Market Analysis and Forecast 2026-2032
Market perspective
The global Blonanserin Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Blonanserin Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Blonanserin Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Blonanserin Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Blonanserin Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Blonanserin Tablets include Intas, Lifecare Neuro Products, Recipharm, Sumitomo Pharma, Taj Life Sciences, LIVZON PHARMACEUTICAL, Shijiazhuang No.4 Pharmaceutical and Xiangzhong Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Blonanserin Tablets, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Blonanserin Tablets, also provides the sales of main regions and countries. Of the upcoming market potential for Blonanserin Tablets, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Blonanserin Tablets sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Blonanserin Tablets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Blonanserin Tablets sales, projected growth trends, production technology, application and end-user industry.
Blonanserin Tablets Segment by Company
Intas
Lifecare Neuro Products
Recipharm
Sumitomo Pharma
Taj Life Sciences
LIVZON PHARMACEUTICAL
Shijiazhuang No.4 Pharmaceutical
Xiangzhong Pharmaceutical
Blonanserin Tablets Segment by Type
4mg
8mg
Blonanserin Tablets Segment by Application
Adults
Children
Blonanserin Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blonanserin Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Blonanserin Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blonanserin Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Blonanserin Tablets in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Blonanserin Tablets manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Blonanserin Tablets sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 4mg
- 8mg
Applications
- Adults
- Children
Companies covered
- Intas
- Lifecare Neuro Products
- Recipharm
- Sumitomo Pharma
- Taj Life Sciences
- LIVZON PHARMACEUTICAL
- Shijiazhuang No.4 Pharmaceutical
- Xiangzhong Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Blonanserin Tablets Market by Type
- 1.2.1 Global Blonanserin Tablets Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 4mg
- 1.2.3 8mg
- 1.3 Blonanserin Tablets Market by Application
- 1.3.1 Global Blonanserin Tablets Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Adults
- 1.3.3 Children
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Blonanserin Tablets Market Dynamics
- 2.1 Blonanserin Tablets Industry Trends
- 2.2 Blonanserin Tablets Industry Drivers
- 2.3 Blonanserin Tablets Industry Opportunities and Challenges
- 2.4 Blonanserin Tablets Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Blonanserin Tablets Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Blonanserin Tablets Revenue by Region
- 3.2.1 Global Blonanserin Tablets Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Blonanserin Tablets Revenue by Region (2021-2026)
- 3.2.3 Global Blonanserin Tablets Revenue by Region (2027-2032)
- 3.2.4 Global Blonanserin Tablets Revenue Market Share by Region (2021-2032)
- 3.3 Global Blonanserin Tablets Sales Estimates and Forecasts 2021-2032
- 3.4 Global Blonanserin Tablets Sales by Region
- 3.4.1 Global Blonanserin Tablets Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Blonanserin Tablets Sales by Region (2021-2026)
- 3.4.3 Global Blonanserin Tablets Sales by Region (2027-2032)
- 3.4.4 Global Blonanserin Tablets Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Blonanserin Tablets Revenue by Manufacturers
- 4.1.1 Global Blonanserin Tablets Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Blonanserin Tablets Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Blonanserin Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Blonanserin Tablets Sales by Manufacturers
- 4.2.1 Global Blonanserin Tablets Sales by Manufacturers (2021-2026)
- 4.2.2 Global Blonanserin Tablets Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Blonanserin Tablets Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Blonanserin Tablets Sales Price by Manufacturers (2021-2026)
- 4.4 Global Blonanserin Tablets Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Blonanserin Tablets Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Blonanserin Tablets Manufacturers, Product Type & Application
- 4.7 Global Blonanserin Tablets Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Blonanserin Tablets Market CR5 and HHI
- 4.8.2 2025 Blonanserin Tablets Tier 1, Tier 2, and Tier 3
5 Blonanserin Tablets Market by Type
- 5.1 Global Blonanserin Tablets Revenue by Type
- 5.1.1 Global Blonanserin Tablets Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Blonanserin Tablets Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Blonanserin Tablets Revenue Market Share by Type (2021-2032)
- 5.2 Global Blonanserin Tablets Sales by Type
- 5.2.1 Global Blonanserin Tablets Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Blonanserin Tablets Sales by Type (2021-2032) & (Kg)
- 5.2.3 Global Blonanserin Tablets Sales Market Share by Type (2021-2032)
- 5.3 Global Blonanserin Tablets Price by Type
6 Blonanserin Tablets Market by Application
- 6.1 Global Blonanserin Tablets Revenue by Application
- 6.1.1 Global Blonanserin Tablets Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Blonanserin Tablets Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Blonanserin Tablets Revenue Market Share by Application (2021-2032)
- 6.2 Global Blonanserin Tablets Sales by Application
- 6.2.1 Global Blonanserin Tablets Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Blonanserin Tablets Sales by Application (2021-2032) & (Kg)
- 6.2.3 Global Blonanserin Tablets Sales Market Share by Application (2021-2032)
- 6.3 Global Blonanserin Tablets Price by Application
7 Company Profiles
- 7.1 Intas
- 7.1.1 Intas Company Information
- 7.1.2 Intas Business Overview
- 7.1.3 Intas Blonanserin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Intas Blonanserin Tablets Product Portfolio
- 7.1.5 Intas Recent Developments
- 7.2 Lifecare Neuro Products
- 7.2.1 Lifecare Neuro Products Company Information
- 7.2.2 Lifecare Neuro Products Business Overview
- 7.2.3 Lifecare Neuro Products Blonanserin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Lifecare Neuro Products Blonanserin Tablets Product Portfolio
- 7.2.5 Lifecare Neuro Products Recent Developments
- 7.3 Recipharm
- 7.3.1 Recipharm Company Information
- 7.3.2 Recipharm Business Overview
- 7.3.3 Recipharm Blonanserin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Recipharm Blonanserin Tablets Product Portfolio
- 7.3.5 Recipharm Recent Developments
- 7.4 Sumitomo Pharma
- 7.4.1 Sumitomo Pharma Company Information
- 7.4.2 Sumitomo Pharma Business Overview
- 7.4.3 Sumitomo Pharma Blonanserin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Sumitomo Pharma Blonanserin Tablets Product Portfolio
- 7.4.5 Sumitomo Pharma Recent Developments
- 7.5 Taj Life Sciences
- 7.5.1 Taj Life Sciences Company Information
- 7.5.2 Taj Life Sciences Business Overview
- 7.5.3 Taj Life Sciences Blonanserin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Taj Life Sciences Blonanserin Tablets Product Portfolio
- 7.5.5 Taj Life Sciences Recent Developments
- 7.6 LIVZON PHARMACEUTICAL
- 7.6.1 LIVZON PHARMACEUTICAL Company Information
- 7.6.2 LIVZON PHARMACEUTICAL Business Overview
- 7.6.3 LIVZON PHARMACEUTICAL Blonanserin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 LIVZON PHARMACEUTICAL Blonanserin Tablets Product Portfolio
- 7.6.5 LIVZON PHARMACEUTICAL Recent Developments
- 7.7 Shijiazhuang No.4 Pharmaceutical
- 7.7.1 Shijiazhuang No.4 Pharmaceutical Company Information
- 7.7.2 Shijiazhuang No.4 Pharmaceutical Business Overview
- 7.7.3 Shijiazhuang No.4 Pharmaceutical Blonanserin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Shijiazhuang No.4 Pharmaceutical Blonanserin Tablets Product Portfolio
- 7.7.5 Shijiazhuang No.4 Pharmaceutical Recent Developments
- 7.8 Xiangzhong Pharmaceutical
- 7.8.1 Xiangzhong Pharmaceutical Company Information
- 7.8.2 Xiangzhong Pharmaceutical Business Overview
- 7.8.3 Xiangzhong Pharmaceutical Blonanserin Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Xiangzhong Pharmaceutical Blonanserin Tablets Product Portfolio
- 7.8.5 Xiangzhong Pharmaceutical Recent Developments
8 North America
- 8.1 North America Blonanserin Tablets Market Size by Type
- 8.1.1 North America Blonanserin Tablets Revenue by Type (2021-2032)
- 8.1.2 North America Blonanserin Tablets Sales by Type (2021-2032)
- 8.1.3 North America Blonanserin Tablets Price by Type (2021-2032)
- 8.2 North America Blonanserin Tablets Market Size by Application
- 8.2.1 North America Blonanserin Tablets Revenue by Application (2021-2032)
- 8.2.2 North America Blonanserin Tablets Sales by Application (2021-2032)
- 8.2.3 North America Blonanserin Tablets Price by Application (2021-2032)
- 8.3 North America Blonanserin Tablets Market Size by Country
- 8.3.1 North America Blonanserin Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Blonanserin Tablets Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Blonanserin Tablets Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Blonanserin Tablets Market Size by Type
- 9.1.1 Europe Blonanserin Tablets Revenue by Type (2021-2032)
- 9.1.2 Europe Blonanserin Tablets Sales by Type (2021-2032)
- 9.1.3 Europe Blonanserin Tablets Price by Type (2021-2032)
- 9.2 Europe Blonanserin Tablets Market Size by Application
- 9.2.1 Europe Blonanserin Tablets Revenue by Application (2021-2032)
- 9.2.2 Europe Blonanserin Tablets Sales by Application (2021-2032)
- 9.2.3 Europe Blonanserin Tablets Price by Application (2021-2032)
- 9.3 Europe Blonanserin Tablets Market Size by Country
- 9.3.1 Europe Blonanserin Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Blonanserin Tablets Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Blonanserin Tablets Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Blonanserin Tablets Market Size by Type
- 10.1.1 China Blonanserin Tablets Revenue by Type (2021-2032)
- 10.1.2 China Blonanserin Tablets Sales by Type (2021-2032)
- 10.1.3 China Blonanserin Tablets Price by Type (2021-2032)
- 10.2 China Blonanserin Tablets Market Size by Application
- 10.2.1 China Blonanserin Tablets Revenue by Application (2021-2032)
- 10.2.2 China Blonanserin Tablets Sales by Application (2021-2032)
- 10.2.3 China Blonanserin Tablets Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Blonanserin Tablets Market Size by Type
- 11.1.1 Asia Blonanserin Tablets Revenue by Type (2021-2032)
- 11.1.2 Asia Blonanserin Tablets Sales by Type (2021-2032)
- 11.1.3 Asia Blonanserin Tablets Price by Type (2021-2032)
- 11.2 Asia Blonanserin Tablets Market Size by Application
- 11.2.1 Asia Blonanserin Tablets Revenue by Application (2021-2032)
- 11.2.2 Asia Blonanserin Tablets Sales by Application (2021-2032)
- 11.2.3 Asia Blonanserin Tablets Price by Application (2021-2032)
- 11.3 Asia Blonanserin Tablets Market Size by Country
- 11.3.1 Asia Blonanserin Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Blonanserin Tablets Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Blonanserin Tablets Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Blonanserin Tablets Market Size by Type
- 12.1.1 SAMEA Blonanserin Tablets Revenue by Type (2021-2032)
- 12.1.2 SAMEA Blonanserin Tablets Sales by Type (2021-2032)
- 12.1.3 SAMEA Blonanserin Tablets Price by Type (2021-2032)
- 12.2 SAMEA Blonanserin Tablets Market Size by Application
- 12.2.1 SAMEA Blonanserin Tablets Revenue by Application (2021-2032)
- 12.2.2 SAMEA Blonanserin Tablets Sales by Application (2021-2032)
- 12.2.3 SAMEA Blonanserin Tablets Price by Application (2021-2032)
- 12.3 SAMEA Blonanserin Tablets Market Size by Country
- 12.3.1 SAMEA Blonanserin Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Blonanserin Tablets Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Blonanserin Tablets Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Blonanserin Tablets Value Chain Analysis
- 13.1.1 Blonanserin Tablets Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Blonanserin Tablets Production Mode & Process
- 13.2 Blonanserin Tablets Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Blonanserin Tablets Distributors
- 13.2.3 Blonanserin Tablets Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst